AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND
Researchers at the University of Essex have used AI to design 'intrabodies,' which are small antibody fragments capable of functioning inside human cells. This breakthrough could lead to new treatments for neurodegenerative diseases like Alzheimer's and Parkinson's by targeting disease-related proteins directly.
Why it matters
This technology provides a novel pathway for addressing diseases that were previously difficult to treat because they originate inside the cell.
Researchers at the University of Essex have developed microscopic medicines that could pave the way for new approaches to treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and motor neurone disease (MND).
The article is a straightforward summary of scientific research and its potential medical applications.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in